CONMED CORP (CNMD) Stock Overview
NYSE:CNMD - US2074101013 - Common Stock
CNMD Key Statistics, Chart & Performance
The current stock price of CNMD is 54.28 USD. In the past month the price increased by 8.52%. In the past year, price decreased by -25.87%.
CNMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.91 | 229.51B | ||
| ISRG | INTUITIVE SURGICAL INC | 58.19 | 167.93B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.14 | 155.75B | ||
| SYK | STRYKER CORP | 30.42 | 149.44B | ||
| MDT | MEDTRONIC PLC | 16.64 | 117.93B | ||
| BDX | BECTON DICKINSON AND CO | 13.64 | 55.79B | ||
| IDXX | IDEXX LABORATORIES INC | 53.4 | 51.31B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.46 | 47.47B | ||
| RMD | RESMED INC | 29.93 | 41.84B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.01 | 34.05B | ||
| DXCM | DEXCOM INC | 44.68 | 29.79B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.53 | 26.58B |
Related stock screener links
About CNMD
Company Profile
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine and lower extremities instrumentation and implants, small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures and fees related to the sales representation, promotion, and marketing of sports medicine allograft tissue. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Company Info
CONMED CORP
11311 Concept Boulevard
Largo FLORIDA 33773 US
CEO: Curt R. Hartman
Employees: 3900
Phone: 17272142974
CONMED CORP / CNMD FAQ
What is the stock price of CONMED CORP today?
The current stock price of CNMD is 54.28 USD. The price decreased by -2.74% in the last trading session.
What is the ticker symbol for CONMED CORP stock?
The exchange symbol of CONMED CORP is CNMD and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is CNMD stock listed?
CNMD stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for CONMED CORP stock?
12 analysts have analysed CNMD and the average price target is 62.99 USD. This implies a price increase of 16.04% is expected in the next year compared to the current price of 54.28. Check the CONMED CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CONMED CORP worth?
CONMED CORP (CNMD) has a market capitalization of 1.68B USD. This makes CNMD a Small Cap stock.
How many employees does CONMED CORP have?
CONMED CORP (CNMD) currently has 3900 employees.
What are the support and resistance levels for CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a support level at 53.95 and a resistance level at 55.82. Check the full technical report for a detailed analysis of CNMD support and resistance levels.
Is CONMED CORP (CNMD) expected to grow?
The Revenue of CONMED CORP (CNMD) is expected to grow by 5.05% in the next year. Check the estimates tab for more information on the CNMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CONMED CORP (CNMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CNMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CNMD, evaluating the profitability, health, valuation and growth aspects
- CONMED CORP (CNMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CONMED CORP (CNMD) Sales and EPS estimates to see what analysts future expectations are.
- CONMED CORP (CNMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CONMED CORP (CNMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- CONMED CORP (CNMD) Stock Chart to make your own analysis
- CONMED CORP (CNMD) Latest news and press-releases to stay up to date.
Does CONMED CORP (CNMD) stock pay dividends?
CONMED CORP (CNMD) has a dividend yield of 1.51%. The yearly dividend amount is currently 0.8. Check the full fundamental report for a detailed analysis of CNMD dividend history, reliability and sustainability.
When does CONMED CORP (CNMD) report earnings?
CONMED CORP (CNMD) will report earnings on 2025-10-28, after the market close.
What is the Price/Earnings (PE) ratio of CONMED CORP (CNMD)?
The PE ratio for CONMED CORP (CNMD) is 12.09. This is based on the reported non-GAAP earnings per share of 4.49 and the current share price of 54.28 USD. Check the full fundamental report for a full analysis of the valuation metrics for CNMD.
What is the Short Interest ratio of CONMED CORP (CNMD) stock?
The outstanding short interest for CONMED CORP (CNMD) is 6.81% of its float. Check the ownership tab for more information on the CNMD short interest.
CNMD Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CNMD. When comparing the yearly performance of all stocks, CNMD is a bad performer in the overall market: 87.22% of all stocks are doing better.
CNMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to CNMD. CNMD scores excellent on profitability, but there are some minor concerns on its financial health.
CNMD Financial Highlights
Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.49. The EPS increased by 20.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.31% | ||
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| Debt/Equity | 0.88 |
CNMD Forecast & Estimates
12 analysts have analysed CNMD and the average price target is 62.99 USD. This implies a price increase of 16.04% is expected in the next year compared to the current price of 54.28.
For the next year, analysts expect an EPS growth of 9.58% and a revenue growth 5.05% for CNMD